Pharmaceutical Company · Gurgaon, Haryana
AstraZeneca Pharma India Limited is the publicly-listed Indian subsidiary of AstraZeneca PLC, the British-Swedish multinational pharmaceutical company. With its India office in Gurgaon, Haryana, AstraZeneca India operates in cardiovascular, respiratory, oncology, and rare disease segments, bringing globally innovative medicines to Indian patients.
AstraZeneca India’s portfolio includes Farxiga/Forxiga (dapagliflozin) for diabetes and heart failure, Brilinta (ticagrelor) for cardiovascular disease, Symbicort (budesonide/formoterol) for asthma and COPD, Tagrisso (osimertinib) for lung cancer, and Imfinzi (durvalumab) for oncology. Roxadustat for anaemia is another key product.
AstraZeneca India is focused on driving access to specialty medicines, particularly in cardiovascular and oncology. The Gurgaon office manages commercial, regulatory, medical, and market access functions. AstraZeneca also has a global innovation centre and technology hub in India.
Company: AstraZeneca Pharma India Ltd.
Location: Gurgaon (Gurugram), Haryana
Business Type: Global Pharmaceutical Subsidiary – Cardiovascular, Oncology & Respiratory
No products found.